Pilot Study: Age Extension of NHS Breast Screening Programme

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this pilot study is to assess the feasibility and acceptability of randomising the phasing-in of the age extension of the NHS Breast Screening Programme in six volunteer sites in different areas of England.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal

NCT06977360

Breast Cancer

RECRUITING NA

Evaluation of an Educational Intervention for Women With Breast Pain

NCT03936842

Breast Pain Mastalgia

UNKNOWN NA

Moving On Study - Pilot Test

NCT04681989

Breast Cancer Female

COMPLETED NA

Restore-B: A Trial Comparing Prepectoral Implant-based Breast Reconstruction With and Without Mesh

NCT06112977

Breast Cancer Risk Reduction

UNKNOWN NA

Evaluation of Accelerated Partial Breast Brachytherapy

NCT00593346

Breast Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Currently all women are invited for breast screening between the ages of 50 and 70. In 2007 the Cancer Reform Strategy announced that from 2012 the NHS Breast Screening Programme would be extended to cover women between the ages of 47 and 73. This means that all women will get two extra screening invitations in their lifetime. It also means that all women will get their first invitation before age 50. As capacity does not allow for full immediate roll out across the whole of England, the age extension will be phased-in with full coverage from 2012. Randomising this phasing-in would provide unbiased evidence on the extent to which it is beneficial to extend the age range for breast screening and whether an extra screen at younger or older ages is more worthwhile. To date there is no clear evidence on this as no trial has looked at the added value of one extra screen within an existing screening programme. This pilot study will assess the feasibility and acceptability of randomising the phasing-in of the age extension in six volunteer sites in different areas of England.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Routine Mammography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Women aged 47-49 invited for breast screening

Group Type ACTIVE_COMPARATOR

Invitation for breast screening

Intervention Type OTHER

Invitation for breast screening to women in different age groups

2

Women aged 71-73 invited for breast screening

Group Type ACTIVE_COMPARATOR

Invitation for breast screening

Intervention Type OTHER

Invitation for breast screening to women in different age groups

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Invitation for breast screening

Invitation for breast screening to women in different age groups

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Invitation for mammogram

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* female, and living in one of the 6 pilot areas, and
* aged 47-49 or 71-73 years, and
* in a screening invitation batch that includes their age group.

Minimum Eligible Age

47 Years

Maximum Eligible Age

73 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes